Human Genome, GSK Drug Has Positive Results

Grab this video:

By copying code you agree to Grab Network's Membership Agreement.
Grab Networks
Grab Networks, Yahoo! Contributor Network
Oct 20, 2009 "Share your voice on Yahoo! websites. Start Here."

Human Genome Sciences (HGSI) said today its experimental lupus drug Benlysta is working even better than it thought in clinical trials. Human Genome is working with GlaxoSmithKline (GSK) on Benlysta, which, if approved, would be the first new drug to treat lupus in half a century.

Credit: Market News Video
Copyright: Market News Video

Published by Grab Networks

A resource for website publishers who want to embed quality, licensed content on a wide variety of topics.  View profile

To comment, please sign in to your Yahoo! account, or sign up for a new account.